A case of Birt-Hogg-Dubé syndrome by Martins, L et al.
Rev Port Pneumol. 2016;22(6):365--367
www.revportpneumol.org
LETTERS TO THE EDITOR
A case of Birt--Hogg--Dubé
syndrome
type-1  pneumocytes  in  the  lungs  and  distal  nephron  in  the
kidneys.3c
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iDear  Editor,
Birt--Hogg--Dubé  syndrome  (BHDS)  or  Hornstein--
Knickenberg  syndrome,  is  a  rare  autosomal  dominant
disorder,  clinically  characterized  by  skin  ﬁbrofolliculo-
mas,  pulmonary  cysts,  which  can  lead  to  spontaneous
pneumothorax,  and  renal  malignancy.1,2
This  condition  is  caused  by  germline  mutations  in  the
tumor  suppressor  gene  folliculin  (FCLN)  (OMIM#135150),
located  in  the  short  arm  of  chromosome  17  (17p11.2).3
The  clinical  manifestations  are  widely  variable  which  may
account  for  BHDS  being  underdiagnosed.1,3
We  present  a  case  of  a  never-smoking,  57-year-old  male,
presented  to  the  emergency  department  with  a  3-week
history  of  dyspnea  and  dry  cough.  His  past  medical  his-
tory  included  a  left  spontaneous  pneumothorax  20  years
ago,  which  was  conservatively  managed,  hypertension  and
chronic  atrial  ﬁbrillation.  On  examination  his  chest  revealed
hyper-resonance  and  reduced  breath  sounds  over  the  left
lung.  Chest  X-ray  showed  a  left-sided  pneumothorax  with
complete  lung  collapse.  Since  it  was  his  second  episode,
chest  drainage  was  performed,  followed  by  thoracoscopic
pleurodesis  (Fig.  1a).  His  chest-CT  showed  multiple  bilat-
eral  sharply  marginated  pulmonary  cysts  (Fig.  1b).  No
subdiaphragmatic  abnormalities  were  identiﬁed.  On  fur-
ther  clinical  examination,  our  patient  was  noted  to  have
pale,  ﬂat  macules  over  his  face,  neck  and  upper  trunk,
for  at  least  20  years.  There  was  also  a  family  history
of  similar  skin  lesions  affecting  his  mother.  The  presence
of  these  skin  lesions  together  with  recurrent  pneumotho-
rax  was  suggestive  of  BHDS,  which  was  further  conﬁrmed
by  genetic  testing.  This  revealed  a  pathogenic  frameshift
c.573  574delinsT  (p.Lys192Argfs*31)  mutation  in  heterozy-
gosity  on  exon  6  of  the  FCLN  gene,  previously  described
by  Lencastre  et  al.,4 which  conﬁrms  the  diagnosis  of
BHDS.
This  syndrome  was  ﬁrst  described  in  1977  by  Birt,  Hogg
and  Dubé  in  a  Canadian  family  in  which  several  members  had
skin  lesions  consisting  of  ﬁbrofolliculomas  with  trichodisco-
mas  and  acrochordons.1,2 More  than  20  years  later,  the  gene
locus  was  mapped  to  chromosome  17p11.2.1--5
Nowadays,  pathogenic  FCLN  mutations  have  been
described  in  more  than  200  families  worldwide.1,3 FCLN  is  a
tumor  suppressor  gene2 expressed  in  many  tissues  like  skin,
m
a
t
oCutaneous  ﬁbrofolliculoma  is  the  most  frequent  clini-
al  manifestation  and  consists  of  multiple,  asymptomatic,
ome-shaped  pale  whitish  papules  with  2--4  mm  diameters
ocated  primarily  in  the  face,  neck  and  upper  torso.1--3
esions  develop  after  25  years  in  82--92%  of  the  affected
ndividuals.2 The  most  feared  complication  of  BHDS  is  renal
ancer.  There  is  a  sevenfold  increased  risk  of  renal  can-
er  compared  to  the  general  population.1,3 Lung  cysts  and
ecurrent  pneumothorax  can  be  the  earliest  and  only  man-
festations  of  BHDS.3 Lung  cysts  have  been  described  in
7--89%  of  BHDS  affected  individuals.  Pulmonary  function
ests  are  usually  normal  despite  the  presence  of  multiple
ung  cysts.1,3
BHDS  lung  cysts  are  distinct  from  bullae  and  blebs.  The
haracteristic  chest  CT  ﬁndings  are  multiple  lung  cysts  of
arious  sizes  with  an  irregular  shape  and  thin  wall,  com-
only  located  in  the  lower  medial  and  subpleural  regions  of
he  lung.6 The  pneumothorax  incidence  in  these  patients  has
een  estimated  to  be  33--38%,3 that  is  a 50-fold  increased
isk  compared  to  unaffected  individuals.1--3 Recently,  Johan-
esma  et  al.  stated  that  probably  5--10%  of  (apparentely)
rimary  spontaneous  pneumothorax  are  caused  by  BHDS.7
We  established  our  patient’s  diagnosis  according  to  the
riteria  proposed  by  Menko  et  al.  which  include  BHDS  clinical
anifestations  and  positive  DNA  testing  result.1
If  genetic  testing  is  positive,  family  members  should
e  referred  for  genetic  counseling  and  FCLN  sequencing.1
henever  BHDS  is  suspected,  chest  CT  is  recommended  to
dentify  lung  cysts  or  the  presence  of  pneumothorax.2 As
neumothorax  recurrence  rate  is  high,  treatment  differs
rom  the  one  recommended  for  primary  spontaneous  pneu-
othorax,  and  according  to  some  authors  pleurodesis  should
e  considered  as  the  ﬁrst  line  treatment  option.6
Pneumococcal  and  annual  inﬂuenza  vaccination  are  rec-
mmended,  as  well  as  periodic  pulmonary  function  testing
f  abnormal  lung  function  is  noticed.6
Family  members  at  risk  of  BHDS  should  start  renal  tumor
creening  with  MRI  when  reaching  the  age  of  21  years,
nd  preferably  every  3  years  thereafter.  Once  a renal  mass
s  detected,  screening  should  become  annual  until  the
ass  has  3 cm  in  diameter,  surgery  being  recommended
fterwards.2
Cutaneous  lesions  in  BHDS  are  asymptomatic  and  hence
reatment  is  offered  for  psychological  and  cosmetic  reasons
nly.1,2
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igure  1  (a)  Thoracoscopy  shows  cluster  of  cysts  in  the  left  superior  lobe  and  (b)  chest-CT  shows  multiple  lung  cysts  with  various
ize and  irregular  shape.
This  is  to  our  knowledge  the  second  reported  case  of  BHDS
n  Portugal.  Our  aim  is  to  alert  to  its  existence  in  order  to
llow  for  early  detection  and  prevention  of  the  more  seri-
us  complications,  such  as  renal  cancer,  both  in  presenting
atients  and  in  relatives  at-risk.
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extiloma: A forgotten diagnosis
o  the  Editor,
he  term  ‘‘textiloma’’  (also  ‘‘gossypiboma’’)  describes  a
ponge  or  other  retained  surgical  material  and  the  sur-
ounding  foreign  body  reaction.  The  most  frequent  sites
can  have  severe  medical  consequences,  such  as  infection
or  formation  of  absesses.  Because  of  its  rarity,  the  diagno-
sis  of  textiloma  is  easily  overlooked,  particularly  when  the
clinical  presentation  is  delayed.  Some  patients  remain  clini-
cally  asymptomatic  for  many  years,  and  then  present  clinical
signs.  The  most  common  clinical  manifestations  are  chest
pain  and  cough.1--5f  intrathoracic  textiloma  are  the  pleural  and  pericardial
avities.  Textilomas  are  essentially  inert  and  lead  to  asep-
ic  foreign  body  reactions  with  ﬁbroblastic  reactions  and
ncapsulation.  This  rare  iatrogenic  complication  of  surgery
p
z
oA  56  year-old  man  was  admitted  with  cough  and  chest
ain.  The  patient  had  undergone  myocardial  revasculari-
ation  6  months  previously.  A  chest  radiograph  showed
pacity  in  the  lower  left  hemithorax.  All  laboratory  tests
